APA (7th ed.) Citation

Mohamed Fathy Kamal, O., Ojeda-Hernández, D. D., Selma-Calvo, B., García-Martín, M., Larriba-González, M. T., Martin-Blanco, L., . . . Gomez-Pinedo, U. (2026). Cell Therapy in Multiple Sclerosis: Clinical Advances, Limitations, and Future Perspectives from Clinical Studies—A Systematic Review. Pharmaceutics, 18(1), 30. https://doi.org/10.3390/pharmaceutics18010030

Chicago Style (17th ed.) Citation

Mohamed Fathy Kamal, Ola, Doddy Denise Ojeda-Hernández, Belén Selma-Calvo, Marina García-Martín, María Teresa Larriba-González, Lucia Martin-Blanco, Jordi A. Matias-Guiu, Jorge Matias-Guiu, and Ulises Gomez-Pinedo. "Cell Therapy in Multiple Sclerosis: Clinical Advances, Limitations, and Future Perspectives from Clinical Studies—A Systematic Review." Pharmaceutics 18, no. 1 (2026): 30. https://doi.org/10.3390/pharmaceutics18010030.

MLA (9th ed.) Citation

Mohamed Fathy Kamal, Ola, et al. "Cell Therapy in Multiple Sclerosis: Clinical Advances, Limitations, and Future Perspectives from Clinical Studies—A Systematic Review." Pharmaceutics, vol. 18, no. 1, 2026, p. 30, https://doi.org/10.3390/pharmaceutics18010030.